Sexual hormones and diabetes: The impact of estradiol in pancreatic β cell

Int Rev Cell Mol Biol. 2021;359:81-138. doi: 10.1016/bs.ircmb.2021.02.004. Epub 2021 Mar 16.ABSTRACTDiabetes is one of the most prevalent metabolic diseases and its incidence is increasing throughout the world. Data from World Health Organization (WHO) point-out that diabetes is a major cause of blindness, kidney failure, heart attacks, stroke and lower limb amputation and estimated 1.6 million deaths were directly caused by it in 2016. Population studies show that the incidence of this disease increases in women after menopause, when the production of estrogen is decreasing in them. Knowing the impact that estrogenic signaling has on insulin-secreting β cells is key to prevention and design of new therapeutic targets. This chapter explores the role of estrogen and their receptors in the regulation of insulin secretion and biosynthesis, proliferation, regeneration and survival in pancreatic β cells. In addition, delves into the genetic animal models developed and its application for the specific study of the different estrogen signaling pathways. Finally, discusses the impact of menopause and hormone replacement therapy on pancreatic β cell function.PMID:33832654 | DOI:10.1016/bs.ircmb.2021.02.004
Source: International Review of Cell and Molecular Biology - Category: Cytology Authors: Source Type: research